Detalhe da pesquisa
1.
PARP1 and POLD2 as prognostic biomarkers for multiple myeloma in autologous stem cell transplant.
Haematologica
; 108(8): 2155-2166, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36861411
2.
Novel CD33 antibodies unravel localization, biology and therapeutic implications of CD33 isoforms.
Future Oncol
; 17(3): 263-277, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33356566
3.
Building a precision oncology workforce by multidisciplinary and case-based learning.
BMC Med Educ
; 21(1): 75, 2021 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-33499867
4.
Gemtuzumab ozogamicin for treatment of newly diagnosed CD33-positive acute myeloid leukemia.
Future Oncol
; 14(30): 3199-3213, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30039981
5.
Proteomics: a new era in pediatric acute myeloid leukemia research.
Haematologica
; 107(10): 2288-2289, 2022 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35021610
6.
Time to reconsider CD33 single nucleotide polymorphism in the response to gemtuzumab ozogamicin.
Haematologica
; 106(11): 2796-2798, 2021 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34092060
7.
Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity.
BMC Genomics
; 16: 483, 2015 Jun 30.
Artigo
Inglês
| MEDLINE | ID: mdl-26121980
8.
PharmGKB summary: lamotrigine pathway, pharmacokinetics and pharmacodynamics.
Pharmacogenet Genomics
; 30(4): 81-90, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32187155
9.
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
Blood
; 121(21): 4366-76, 2013 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-23538338
10.
Impact of CD33 and ABCB1 single nucleotide polymorphisms in patients with acute myeloid leukemia and advanced myeloid malignancies treated with decitabine plus gemtuzumab ozogamicin.
Am J Hematol
; 95(9): E225-E228, 2020 09.
Artigo
Inglês
| MEDLINE | ID: mdl-32356320
11.
A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia.
Am J Hematol
; 89(9): 889-95, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24891274
12.
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric AML: a report from the Children's Oncology Group.
Clin Cancer Res
; 2024 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38197878
13.
Current Landscape of Genome-Wide Association Studies in Acute Myeloid Leukemia: A Review.
Cancers (Basel)
; 15(14)2023 Jul 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37509244
14.
Polygenic Pharmacogenomic Markers as Predictors of Toxicity Phenotypes in the Treatment of Acute Lymphoblastic Leukemia: A Single-Center Study.
JCO Precis Oncol
; 7: e2200580, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36952646
15.
Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.
Pharmacogenomics
; 24(13): 731-738, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37702060
16.
SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia.
Blood Adv
; 7(11): 2538-2550, 2023 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-36689724
17.
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML.
Blood Adv
; 7(9): 1769-1783, 2023 05 09.
Artigo
Inglês
| MEDLINE | ID: mdl-36111891
18.
Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice.
Front Oncol
; 12: 1045016, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36439420
19.
Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation.
Pharmaceutics
; 14(11)2022 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36432661
20.
Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation.
J Clin Oncol
; 40(7): 772-783, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34990262